Search Results
Search results for "Nobel Prize"
Results found for "Nobel Prize"
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
We identified a novel GRK3 inhibitor, LD2, through a chemical-library screen.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- Pharmacology at Your Fingertips: Terry’s Corner Launches
must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine to novel
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Become a Premium Member to access both courses at a reduced price. Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 Adenosine A2a receptor: novel
- 📰 GPCR Weekly News
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Heptares sign agreement to advance cancer immunotherapy candidate into clinical trials "HTL0039732 is a novel
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
presented this important pre-clinical work at SIRS2022 confirming the ability of the highly selective novel
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
These advances have paved the way for development of novel ligands for different therapeutic applications
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
these results link the morphogenetic effects of HH to the apico-basal distribution of SMO and provide a novel
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Exscientia is 10 years old this July!
Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of novel
- PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal...
ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal mast cells "A novel
- Profiling Immune Cell and Platelet Transcriptomes
hematopoietic stem cells, suggesting a potential role in regulating red blood cell production and offering a novel
- From Failed Experiments to Predictive GPCR Models
Using virtual screening, he was able to identify novel ligands that aligned with experimental findings on virtual screening from commercial compound libraries, the work inevitably reaches a point where novel
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel
- 📰 GPCR Weekly News - January 9 to 15, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Obesity Pipelines Beyond GLP-1s Septerna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Cardiology, Endocrinology, and Taste Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled receptor (GPCR) structures reveal novel
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
Significant advancements in the cellular biology of G protein-coupled receptors (GPCRs) about a novel
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
selectivity/biased signaling has led to the discovery of biased compounds as both research tools and novel
- 📰 GPCR Weekly News, February 13 to 19, 2023
GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Frontiers 2025 , a conference organized by both the EFMC and the ACSMEDI, in an effort to share the most novel
- 📰 GPCR Weekly News, April 3 to 9, 2023
GPCRs in Cardiology, Endocrinology, and Taste Novel roles for G protein-coupled receptor kinases in cardiac Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Huntington's disease therapy Rational design of highly stabilized and selective adrenomedullin analogs Novel Carmot Therapeutics Enters into Definitive Merger Agreement with Roche New Clinical Trial Explores Novel






